Overall, the results show that FGFR2c expression impacts on cell sensitivity to FGF2 in terms of EMT signature and that PKCε is involved in both receptor mediated EMT response and inhibition of autophagy, pointing on this substrate as a potential therapeutic target in counteracting cancer progression. Here, FGF2 is linked to cancer.